hosted by
publicationslist.org
    

Dr Shyamala Huilgol


Senior Clinical Lecturer
University of Adelaide
South Australia

Journal articles

2010
Paul Armenores, Shyamala C Huilgol (2010)  Spiral flap for closure of nasal ala defects.   Australas J Dermatol 51: 4. 279-280 Nov  
Abstract: Despite the existence of numerous methods to close nasal ala defects, many produce distortion of the surrounding tissues and obvious scarring. The spiral flap produces little or no distortion and well-camouflaged scars. We demonstrate these benefits through the presentation of two successful case reports.
Notes:
Paul S Cannon, Brett O'Donnell, Shyamala C Huilgol, Dinesh Selva (2010)  The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions.   Br J Ophthalmol Aug  
Abstract: Aim To describe the ophthalmic side-effects of topical imiquimod for periocular actinic keratoses, squamous cell carcinoma in situ and basal cell carcinoma. Method A retrospective study was carried out in two centres of all patients who underwent topical imiquimod therapy between January 2004 and January 2009. Imiquimod was applied three times weekly for 4-6 weeks. Diagnosis of the lesions, complications, clinical resolution and long-term ophthalmic side-effects was recorded. Patients on therapy were reviewed fortnightly and then every 6 weeks following completion of treatment. Results 47 patients were identified; the mean age was 74 years. 37 patients had actinic keratoses, seven patients had Bowen disease, and three patients had BCC. The lower lid was the commonest site involved (68%). Application site erythema occurred in all patients. Conjunctivitis occurred in 15 patients, and six patients complained of ocular stinging on application of imiquimod. One patient had a staphylococcal keratitis, which responded to topical antibiotic and steroid therapy. Two patients required oral antibiotics for preseptal cellulitis. Three patients had delayed conjunctivitis at a mean of 2.3 weeks. Nine patients discontinued imiquimod due to ocular irritation and conjunctivitis, of whom four patients recommenced and finished the treatment after a rest period. At a mean follow-up of 16 weeks, 34 patients had clinical resolution of the periocular lesions and no patient had any residual ophthalmic side-effects from imiquimod. Conclusion Conjunctivitis and ocular stinging were the commonest ophthalmic side-effects encountered with the application of imiquimod for periocular skin lesions. These effects were temporary and resolved on terminating the imiquimod therapy.
Notes:
Paul Armenores, Craig L James, Patrick C Walker, Shyamala C Huilgol (2010)  Treatment of actinic cheilitis with the Er:YAG laser.   J Am Acad Dermatol 63: 4. 642-646 Oct  
Abstract: Actinic cheilitis is a common condition with the potential to develop into squamous cell carcinoma. Current treatments have varying cure rates and complications. The role of the erbium:yttrium-aluminum-garnet (Er:YAG) laser in the treatment of actinic cheilitis has not been widely published, despite offering theoretical advantages over current treatment modalities.
Notes:
2009
Siew-Yin Then, Raman Malhotra, Richard Barlow, Habib Kurwa, Shyamala Huilgol, Naresh Joshi, Jane Olver, Richard Collin, Dinesh Selva (2009)  Early cure rates with narrow-margin slow-Mohs surgery for periocular malignant melanoma.   Dermatol Surg 35: 1. 17-23 Jan  
Abstract: Staged excision with rush-processed paraffin-embedded tissue sections (Slow-Mohs) is an effective treatment for periocular melanoma. Although there is no consensus on initial margins of excision, narrower margins in the eyelids have the functionally and cosmetically important consequence of smaller postoperative wounds.
Notes:
Vernon S C Pua, Shyamala Huilgol, Dudley Hill (2009)  Evaluation of the treatment of non-melanoma skin cancers by surgical excision.   Australas J Dermatol 50: 3. 171-175 Aug  
Abstract: A retrospective study of all non-melanoma skin cancers excised by two dermatologists at a private practice in 2004 (excluding Mohs microscopic surgery cases) was conducted. Two hundred and forty-one patients were treated, with a total of 453 tumours excised. The overall incomplete excision rate was 2.2% (10/453). For basal cell cancers, the incomplete excision rate was 1.54% (5/324) and for squamous cell cancers including Bowen's disease the incomplete excision rate was 3.9% (5/129). The majority of repairs were primary closures (82.6%). Although a significant proportion of the tumours were from the head and neck region (45.9%), this study demonstrated that careful patient selection, experience of the surgeon and adherence to recommended excision margins can achieve a favourable incomplete excision rate.
Notes:
2008
Rajeev Jain, Venkatesh C Prabhakaran, Shyamala C Huilgol, Neil Gehling, Craig L James, Dinesh Selva (2008)  Eccrine porocarcinoma of the upper eyelid.   Ophthal Plast Reconstr Surg 24: 3. 221-223 May/Jun  
Abstract: Eccrine porocarcinoma is an unusual, locally aggressive tumor with a significant risk of metastasis and recurrence after surgical excision. Eyelid involvement is rare. We describe a 70-year-old man who was examined for right upper eyelid eccrine porocarcinoma that was treated with Mohs surgery. Eccrine porocarcinoma should be considered in the differential diagnosis of malignant eyelid tumors.
Notes:
2007
Seongmu Lee, Dinesh Selva, Shyamala C Huilgol, Robert A Goldberg, Igal Leibovitch (2007)  Pharmacological treatments for basal cell carcinoma.   Drugs 67: 6. 915-934  
Abstract: Basal cell carcinoma (BCC) is the most common non-melanoma skin cancer, and its incidence continues to rise. Current management options are numerous and focus on tumour eradication while maximising cosmetic and functional capacity. Although surgery continues to be considered the main treatment modality, new pharmacological agents, such as immunomodulators, topical chemotherapeutic agents and photodynamic therapy, have emerged and show promising results. Pharmacological agents offer the potential for lower morbidity and improved tissue preservation compared with surgery and radiotherapy. However, pharmacological treatments possess higher failure rates when compared with surgery, and most studies have investigated only low-risk lesions. Several prospective, randomised, double-blind, vehicle-controlled studies have established the efficacy of imiquimod for superficial BCC. This review summarises the evidence regarding the mechanism, efficacy and safety of pharmacological agents based on the literature from the past 10 years. Experimental treatments that have been successfully utilised in the treatment of BCC are also discussed. Treatment of BCC with other agents, such as tazarotene, glycoalkaloid (BEC-5) cream, cidofovir and calcium dobesilate have been reported, but further studies are needed to ascertain the efficacy and adverse-effect profiles of these treatments.
Notes:
Venkatesh C Prabhakaran, Aanchal Gupta, Shyamala C Huilgol, Dinesh Selva (2007)  Basal cell carcinoma of the eyelids.   Compr Ophthalmol Update 8: 1. 1-14 Jan/Feb  
Abstract: Basal cell carcinoma is the most common malignancy in humans, and it is also the most frequent periocular malignancy. Although a slow-growing tumor, it can lead to significant morbidity in the periocular region as a result of orbital invasion. As clinical presentation can be very variable, biopsy is recommended for all suspicious lesions. Management needs to be individualized, taking into account patient factors, tumor characteristics, and histological subtype. Several treatment modalities have been proposed, but surgical excision with monitoring of excision margins has the highest cure rate. As a certain percentage of tumors will recur regardless of treatment modality, careful patient counseling and/or long-term follow-up is recommended. In this review, we discuss the risk factors, pathology, molecular biology, clinical features, and management of eyelid basal cell carcinoma.
Notes:
2006
Igal Leibovitch, Dinesh Selva, Shyamala Huilgol, Garry Davis, Thomas Dodd, Craig L James (2006)  Intraepithelial sebaceous carcinoma of the eyelid misdiagnosed as Bowen's disease.   J Cutan Pathol 33: 4. 303-308 Apr  
Abstract: Sebaceous carcinoma (SC) is well known for its ability to masquerade clinically and histologically as a variety of periocular conditions resulting in a delayed diagnosis. We present a series of periocular SC cases and discuss the difficulties in histopathological diagnosis when this tumor presents with a Bowenoid pattern of intraepithelial spread.
Notes:
Igal Leibovitch, Shyamala C Huilgol, Shawn Richards, Robert Paver, Dinesh Selva (2006)  Periocular microcystic adnexal carcinoma: management and outcome with Mohs' micrographic surgery.   Ophthalmologica 220: 2. 109-113  
Abstract: To report a series of patients with periocular microcystic adnexal carcinoma (MAC) treated with Mohs' micrographic surgery (MMS).
Notes:
I Mavrikakis, R Malhotra, D Selva, S C Huilgol, R Barlow (2006)  Linear basal cell carcinoma: A distinct clinical entity.   J Plast Reconstr Aesthet Surg 59: 4. 419-423  
Abstract: The purpose of the study is to describe linear basal cell carcinoma (BCC) as a distinct clinical entity, and highlight its existence to the plastic surgery literature. A Medline and PubMed literature search was conducted, and 33 reported cases of linear BCC were analysed. Of these 33 cases, the most common site for linear BCC was the periocular region, accounting for 49% (n= 16). The most common histologic subtype, was nodular BCC, accounting for 50% (n= 17). Of the 33 reported cases the postoperative defect size was mentioned in five cases only. None of these would have been completely excised if a 2 mm margin was applied, and only one out of five if a 4 mm margin was applied. Linear BCC is a distinct clinical entity. Presence of the tumour along relaxing skin tension lines, increase in subclinical extension, and aggressive tumour behavior are reported observations. Because of these observations it is suggested that margin-controlled excision should be considered for linear BCC.
Notes:
Ioannis Mavrikakis, Raman Malhotra, Richard Barlow, Shyamala C Huilgol, Dinesh Selva (2006)  Linear basal cell carcinoma: a distinct clinical entity in the periocular region.   Ophthalmology 113: 2. 338-342 Feb  
Abstract: To report periocular linear basal cell carcinoma (BCC) as a distinct clinical entity, and to highlight its existence in the ophthalmic literature.
Notes:
Shane R Durkin, Dinesh Selva, Shyamala C Huilgol, Stephen Guy, Igal Leibovitch (2006)  Recurrent staphylococcal conjunctivitis associated with facial impetigo contagiosa.   Am J Ophthalmol 141: 1. 189-190 Jan  
Abstract: To report the uncommon occurrence of impetigo contagiosa in the setting of recurrent staphylococcal conjunctivitis.
Notes:
Igal Leibovitch, Garry Davis, Shyamala C Huilgol, John Crompton, Craig L James, Dinesh Selva (2006)  An unusual presentation of periocular Merkel cell carcinoma.   J Cutan Pathol 33 Suppl 2: 39-41 Sep  
Abstract: Merkel cell carcinoma (MCC) is an uncommon but potentially aggressive tumor. We describe a rare presentation of MMC of the upper lid.
Notes:
J J Khong, R J Casson, S C Huilgol, D Selva (2006)  Madarosis.   Surv Ophthalmol 51: 6. 550-560 Nov/Dec  
Abstract: Madarosis may be a presenting feature of a number of vision and life-threatening conditions, including herpes zoster, leprosy, HIV/AIDS, trachoma, malignant eyelid tumors, discoid lupus, scleroderma, and hypothyroidism. It may occur via two broad pathogenic pathways: scarring and non-scarring, which indicates the potential for lash re-growth. Madarosis may occur as an isolated finding or together with loss of other body and scalp hair. The etiology of madarosis can be further divided into dermatological, infection, endocrine, neoplastic, drug-related, congenital, and trauma. This report includes salient points in the clinical history and examination of patients with madarosis, with an emphasis on excluding or diagnosing visual or life threatening disorders associated with madarosis.
Notes:
Igal Leibovitch, Shyamala C Huilgol, Shawn Richards, Robert Paver, Dinesh Selva (2006)  Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.   Dermatol Surg 32: 11. 1369-1374 Nov  
Abstract: There are only a small number of reports on the outcome of scalp tumors treated with Mohs micrographic surgery (MMS).
Notes:
Igal Leibovitch, Shyamala C Huilgol, Shawn Richards, Robert Paver, Dinesh Selva (2006)  The Australian Mohs database: short-term recipient-site complications in full-thickness skin grafts.   Dermatol Surg 32: 11. 1364-1368 Nov  
Abstract: There are only a few reports on the outcome with full-thickness skin grafts (FTSG) in defect reconstruction after Mohs micrographic surgery (MMS).
Notes:
Colin G Ooi, Craig L James, Shyamala C Huilgol (2006)  Metastatic Bowen carcinoma.   Australas J Dermatol 47: 4. 277-280 Nov  
Abstract: A 72-year-old man presented with basaloid squamous cell carcinoma metastatic to both lungs that was morphologically similar to recurrent, invasive moderately to poorly differentiated carcinoma arising from persistent Bowen's disease of the right cheek. The original lesion of invasive moderately differentiated squamous cell carcinoma arising in Bowen's disease had been excised 11 years previously. Mohs' surgery was performed for the recurrent lesion on the cheek 12 months prior to detection of lung metastases. He died of respiratory failure 19 months following diagnosis of his metastatic disease. Our case reflects the potentially aggressive nature of invasive squamous cell carcinoma arising from Bowen's disease and highlights the importance of approaching this entity with a view to complete surgical excision with adequate margins.
Notes:
2005
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Shawn Richards, Robert Paver (2005)  Basosquamous carcinoma: treatment with Mohs micrographic surgery.   Cancer 104: 1. 170-175 Jul  
Abstract: Basosquamous carcinoma (BSC) is a rare tumor defined as a basal cell carcinoma (BCC) differentiating into squamous cell carcinoma (SCC). It is reported to have a high rate of recurrence with standard wide local excision. The aim of the current study was to report a large series of patients with BSC treated with Mohs micrographic surgery (MMS).
Notes:
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Dudley Hill, Shawn Richards, Robert Paver (2005)  Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.   J Am Acad Dermatol 53: 2. 253-260 Aug  
Abstract: Only a few reports have been published on the long-term outcome of surgical excision of cutaneous squamous cell carcinoma (SCC).
Notes:
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Shawn Richards, Robert Paver (2005)  Cutaneous squamous carcinoma in situ (Bowen's disease): treatment with Mohs micrographic surgery.   J Am Acad Dermatol 52: 6. 997-1002 Jun  
Abstract: Bowen's disease (BD), also known as squamous intraepidermal carcinoma, is a malignant skin tumor with a potential to progress to invasive carcinoma.
Notes:
I Leibovitch, S C Huilgol, J D Hsuan, D Selva (2005)  Incidence of host site complications in periocular full thickness skin grafts.   Br J Ophthalmol 89: 2. 219-222 Feb  
Abstract: To evaluate the complications of periocular full thickness skin grafts (FTSG) in patients treated with Mohs' micrographic surgery (MMS) for periocular malignancy.
Notes:
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Dudley Hill, Shawn Richards, Robert Paver (2005)  Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion.   J Am Acad Dermatol 53: 2. 261-266 Aug  
Abstract: Perineural invasion (PNI) is an important histologic factor that plays a significant role in cutaneous tumors' aggressiveness.
Notes:
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Karyn Lun, Shawn Richards, Robert Paver (2005)  Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery.   J Am Acad Dermatol 52: 2. 295-300 Feb  
Abstract: Microcystic adnexal carcinoma (MAC) is reported to have a high rate of recurrence with standard wide local excision.
Notes:
Jwu Jin Khong, Celia S Chen, Craig L James, Shyamala C Huilgol, Brett A O'Donnell, Timothy J Sullivan, Dinesh Selva (2005)  Malignant fibrous histiocytoma of the eyelid: differential diagnosis and management.   Ophthal Plast Reconstr Surg 21: 2. 103-108 Mar  
Abstract: Malignant fibrous histiocytoma (MFH) is a pleomorphic soft tissue sarcoma that occurs rarely in the periocular region. The purpose of this study was to present a case series of periocular MFH and to discuss the differential diagnosis and management.
Notes:
Igal Leibovitch, Colin Ooi, Shyamala C Huilgol, Cathy Reid, Craig L James, Dinesh Selva (2005)  Pyodermatitis-pyostomatitis vegetans of the eyelids case report and review of the literature.   Ophthalmology 112: 10. 1809-1813 Oct  
Abstract: To present the first reported case of eyelid involvement in pyodermatitis-pyostomatitis vegetans (PDPSV) leading to the diagnosis of ulcerative colitis, and to review the literature.
Notes:
Caroline Laforest, Shyamala C Huilgol, Robert Casson, Dinesh Selva, Igal Leibovitch (2005)  Autoimmune bullous diseases: ocular manifestations and management.   Drugs 65: 13. 1767-1779  
Abstract: The ocular manifestations of autoimmune bullous diseases are common and potentially sight-threatening. Major ophthalmic involvement is most commonly seen in mucous membrane pemphigoid (cicatricial pemphigoid), epidermolysis bullosa acquisita, linear IgA bullous disease, pemphigus vulgaris and paraneoplastic pemphigus. The main pathological process is related to autoimmune-induced conjunctival inflammation with consequent lid and corneal pathology, which may eventually result in permanent visual loss. Ocular involvement can be asymptomatic. Early detection is aided by careful attention to symptoms and signs of early ophthalmic disease. Ocular disease can be difficult to treat and management usually involves systemic therapy with immunomodulators to control inflammation and prevent progression to irreversible blindness, as well as surgical intervention in advanced disease. Recent advances in treatment, including methotrexate, mycophenolate mofetil, monoclonal antibodies and topical tacrolimus therapies, have led to promising results.
Notes:
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Shawn Richards, Robert Paver (2005)  Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.   J Am Acad Dermatol 53: 3. 445-451 Sep  
Abstract: Only a few prospective studies have been published on surgical treatments for cutaneous basal cell carcinoma (BCC).
Notes:
I Leibovitch, S C Huilgol, C L James, J D Hsuan, G Davis, D Selva (2005)  Periocular keratoacanthoma: can we always rely on the clinical diagnosis?   Br J Ophthalmol 89: 9. 1201-1204 Sep  
Abstract: To present a series of patients with a clinical diagnosis of periocular keratoacanthoma and assess the incidence of histologically proven invasive squamous cell carcinoma (SCC).
Notes:
I Leibovitch, S C Huilgol, D Selva, R Paver, S Richards (2005)  Cutaneous lip tumours treated with Mohs micrographic surgery: clinical features and surgical outcome.   Br J Dermatol 153: 6. 1147-1152 Dec  
Abstract: The Australian Mohs micrographic surgery (MMS) database was initiated in 1993 by the Skin and Cancer Foundation Australia (SCFA) with the aim of collecting prospective data, and involved all Mohs surgeons in the country.
Notes:
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Shawn Richards, Robert Paver (2005)  Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.   J Am Acad Dermatol 53: 3. 458-463 Sep  
Abstract: Perineural invasion (PNI) is an important factor may possibly influence the aggressiveness of basal cell carcinoma (BCC).
Notes:
Igal Leibovitch, Shyamala C Huilgol, Dinesh Selva, Shawn Richards, Robert Paver (2005)  Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.   J Am Acad Dermatol 53: 3. 452-457 Sep  
Abstract: Long-term follow-up is essential to evaluate the role of Mohs micrographic surgery (MMS) in the treatment for cutaneous basal cell carcinoma (BCC).
Notes:
2004
Raman Malhotra, Shyamala C Huilgol, Nghi T Huynh, Dinesh Selva (2004)  The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.   Ophthalmology 111: 4. 624-630 Apr  
Abstract: To present the findings of all patients with periocular basal cell carcinoma (BCC) treated with Mohs' micrographic surgery (MMS) in Australia between 1993 and 1999.
Notes:
Raman Malhotra, Shyamala C Huilgol, Nghi T Huynh, Dinesh Selva (2004)  The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.   Ophthalmology 111: 4. 631-636 Apr  
Abstract: To report the outcome with 5-year strict follow-up (only cases where 5-year follow-up is available) of all patients with periocular basal cell carcinoma (BCC) treated with Mohs' micrographic surgery (MMS) in Australia between 1993 and 1996.
Notes:
Hoang Ly, Dinesh Selva, Craig L James, Shyamala C Huilgol (2004)  Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.   Australas J Dermatol 45: 2. 106-109 May  
Abstract: Atypical fibroxanthoma (AFX) and malignant fibrous histiocytoma (MFH) are neoplasms of probable fibrohistiocytic lineage. The precise relationship between AFX and MFH remains controversial. We present two cases in which a lesion was excised from the face of an elderly person and reported as AFX. Both cases recurred within 12 months and were reclassified as MFH. They were excised with slow Mohs' micrographic surgery, with adjuvant radiotherapy in one case. In the other, a further recurrence was treated with orbital exenteration and radiotherapy. We review the difficulties in differentiating between AFX and MFH and the implications for treatment.
Notes:
Tze F Lai, Shyamala C Huilgol, Dinesh Selva, Craig L James (2004)  Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma.   Dermatol Surg 30: 2 Pt 1. 222-225 Feb  
Abstract: Sebaceous carcinoma (SC) accounts for 1% to 5.5% of all eyelid malignancies. Diagnosis is often delayed because of its ability to masquerade as other periocular lesions both clinically and histologically.
Notes:
Raman Malhotra, Shyamala C Huilgol, Nghi T Huynh, Dinesh Selva (2004)  The Australian Mohs database: periocular squamous cell carcinoma.   Ophthalmology 111: 4. 617-623 Apr  
Abstract: To present the results of all patients with periocular squamous cell carcinoma (SCC) treated with Mohs' micrographic surgery (MMS) in Australia between 1993 and 1999.
Notes:
Raman Malhotra, Craig L James, Dinesh Selva, Nghi Huynh, Shyamala C Huilgol (2004)  The Australian Mohs database: periocular squamous intraepidermal carcinoma.   Ophthalmology 111: 10. 1925-1929 Oct  
Abstract: To present the findings and report the outcomes of all patients with periocular squamous intraepidermal carcinoma (IEC) treated with Mohs micrographic surgery (MMS) in Australia between 1993 and 1999.
Notes:
Tze Foon Lai, Igal Leibovitch, Craig James, Shyamala C Huilgol, Dinesh Selva (2004)  Rosacea lymphoedema of the eyelid.   Acta Ophthalmol Scand 82: 6. 765-767 Dec  
Abstract: To present a patient with rosacea lymphoedema of one upper eyelid resulting in unilateral complete ptosis.
Notes:
Shyamala C Huilgol, Dinesh Selva, Celia Chen, Dudley C Hill, Craig L James, Amanda Gramp, Raman Malhotra (2004)  Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.   Arch Dermatol 140: 9. 1087-1092 Sep  
Abstract: To assess the margins required for excision of lentigo maligna (LM) and lentigo maligna melanoma (LMM) by the technique of mapped serial excision (MSE), and to assess the efficacy of MSE.
Notes:
2003
Dinesh Selva, Lloyd Hale, Keith Bouskill, Shyamala C Huilgol (2003)  Recurrent morphoeic basal cell carcinoma at the lateral canthus with orbitocranial invasion.   Australas J Dermatol 44: 2. 126-128 May  
Abstract: We present a case of recurrent, nodulocystic and morphoeic basal cell carcinoma (BCC) at the lateral canthus, with clinically silent orbital and intracranial invasion which was treated with radiotherapy. Orbital invasion is a rare complication of periocular BCC and occurs primarily in high-risk canthal lesions. Preoperative ophthalmological review and imaging should be considered in these cases.
Notes:
Dinesh Selva, Celia S Chen, Craig L James, Shyamala C Huilgol (2003)  Discoid lupus erythematosus presenting as madarosis.   Am J Ophthalmol 136: 3. 545-546 Sep  
Abstract: Discoid lupus erythematosus (DLE) is an autoimmune disorder that usually affects the sun-exposed skin. Periocular involvement occurs uncommonly and may progress from eyelid erythema to scarring and madarosis.
Notes:
Tze Foon Lai, Shyamala C Huilgol, Craig L James, Dinesh Selva (2003)  Trichilemmal carcinoma of the upper eyelid.   Acta Ophthalmol Scand 81: 5. 536-538 Oct  
Abstract: Trichilemmal carcinoma (TLC) is a rare adnexal tumour related to the external hair sheath. We describe the first case of TLC on the upper eyelid to be treated with Mohs micrographic surgery.
Notes:
Leah M Giesecke, Catherine M Reid, Craig L James, Shyamala C Huilgol (2003)  Giant keratoacanthoma arising in hypertrophic lichen planus.   Australas J Dermatol 44: 4. 267-269 Nov  
Abstract: A 45-year-old man presented with a rapidly enlarging tumour in an area of long-standing hypertrophic lichen planus of the lower leg. Histological examination of the resected specimen showed it to be a giant keratoacanthoma measuring 37 x 57 mm. Neoplastic change is a rarely reported complication of chronic variants of cutaneous lichen planus. To date there have been only two reports of keratoacanthoma development in association with lichen planus.
Notes:
Raman Malhotra, Celia Chen, Shyamala C Huilgol, Dudley C Hill, Dinesh Selva (2003)  Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.   Ophthalmology 110: 10. 2011-2018 Oct  
Abstract: To report the early cure rate for periocular lentigo maligna (LM) and LM melanoma (LMM), using modified Mohs surgery with vertically cut paraffin-embedded sections (mapped serial excision [MSE]). A secondary aim was to identify differences in the clinical features and outcomes between periocular LM and LMM and those found elsewhere on the head and neck.
Notes:
2002
Shyamala C Huilgol, Sallie Neill, Richard J Barlow (2002)  CO(2) laser therapy of vulval lymphangiectasia and lymphangioma circumscriptum.   Dermatol Surg 28: 7. 575-577 Jul  
Abstract: Lymphangiectasia is a disorder of superficial lymphatics resulting from obstruction of previously normal deep lymphatics, while lymphangioma circumscriptum describes a deep dermal and subcutaneous lymphatic malformation with secondary superficial ectatic changes. Previous case reports have suggested the effectiveness of CO2 laser treatment.
Notes:
2001
S C Huilgol, E Poon, E Calonje, P T Seed, R R Huilgol, A C Markey, R J Barlow (2001)  Scanned continuous wave CO2 laser resurfacing: a closer look at the different scanning modes.   Dermatol Surg 27: 5. 467-470 May  
Abstract: The immediate effects of CO2 laser resurfacing include tissue ablation and residual thermal damage. These laser-tissue interactions are shaped by parameters including fluence, dwell time, and number of passes.
Notes:
R C Bittencourt, S C Huilgol, P T Seed, E Calonje, A C Markey, R J Barlow (2001)  Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow-up.   J Am Acad Dermatol 45: 5. 731-735 Nov  
Abstract: Facial angiofibromas in tuberous sclerosis have been managed with various treatment modalities, including carbon dioxide (CO(2)) laser resurfacing.
Notes:
2000
S Madani, S C Huilgol, A Carruthers (2000)  Unplanned incomplete Mohs micrographic surgery.   J Am Acad Dermatol 42: 5 Pt 1. 814-819 May  
Abstract: Incomplete Mohs micrographic surgery (MMS) is the cessation of MMS while the tumor margins are known to be still positive.
Notes:
1999
S C Huilgol, A Carruthers, R L Burns, D N Selva (1999)  Malar fat pad elevation: An aid to closure.   Dermatol Surg 25: 11. 872-874 Nov  
Abstract: In closure of defects inferior to the eye, it is important to avoid inducing lower lid ectropion.
Notes:
J Setterfield, S C Huilgol, M M Black (1999)  Generalised granuloma annulare successfully treated with PUVA.   Clin Exp Dermatol 24: 6. 458-460 Nov  
Abstract: Disseminated granuloma annulare is an uncommon disorder in which both topical and systemic therapy may have limited success. Anecdotal reports have suggested that PUVA may result in complete clearance of disease; however, maintenance PUVA therapy has usually been required in order to maintain remission. We report the successful treatment of a patient with 5-methoxypsoralen over a 7-month period who remained in remission during a 20-month follow up period.
Notes:
1998
S C Huilgol, N Ramnarain, P Carrington, I M Leigh, M M Black (1998)  Cytokeratins in primary cutaneous amyloidosis.   Australas J Dermatol 39: 2. 81-85 May  
Abstract: The expression of keratins was investigated immunohistochemically on formalin-fixed and snap-frozen primary cutaneous amyloidosis tissue with a panel of monospecific and polyspecific antikeratin antibodies, with recognized keratins K1, K5, K6, K7, K8, K10, K14, K16, K17, K18 and K19. Amyloid deposits in frozen sections of seven cases of macular amyloidosis and lichen amyloidosus always reacted with antibodies LP34 (labelling K5, K6 and K18), MNF 116 (labelling K5, K6, K8, K10, K17 and K18), and RCK 102 (labelling K5 and K8); frozen sections in one case each of the seven cases also reacted with antibodies LL001 (labelling K14), LP1K (labelling K7 and K17), and LP2K (labelling K19). In formalin-fixed sections of 13 cases of macular amyloidosis and lichen amyloidosus, amyloid deposits were labelled with LP34 in three sections, MNF 116 in four sections, LL020 (labelling keratins K5 and K6) in one section, and LP2K in two sections. In nodular primary cutaneous amyloidosis, amyloid deposits were not labelled with any antikeratin antibodies. These data confirm that amyloid in macular amyloidosis and lichen amyloidosus contains keratin epitopes, and suggests derivation of the fibrillar component from keratin intermediate filaments. Several different keratins appear to undergo conversion to amyloid. LP34, MNF 116 and RCK 102 antibodies, which have in common the labelling of keratin K5, may be useful in the diagnosis of macular and papular amyloidosis with frozen tissue sections.
Notes:
S C Huilgol, D Fenton, H Pambakian, R Cerio, D M McGibbon, M M Black (1998)  Fatal cytophagic panniculitis and haemophagocytic syndrome.   Clin Exp Dermatol 23: 2. 51-55 Mar  
Abstract: We present two fatal cases of cytophagic panniculitis (CP) and haemophagocytic syndrome (HPS). In the first of these, there was an underlying T-cell lymphoma but in the second no associated disease was found. HPS is a frequently fatal disorder of immune regulation, characterized by fever, histiocytic haemophagocytosis, hepatosplenomegaly, pancytopenia, hypertriglyceridaemia and coagulopathy; CP is a less common manifestation. A number of benign and malignant conditions may present with HPS, the clinical findings and investigations aiding in determining an underlying disorder. Therapy is both supportive and directed at any associated illness, but often very difficult as diagnosis is delayed.
Notes:
1996
S C Huilgol, R J Barlow, A C Markey (1996)  Failure of pulsed dye laser therapy for resistant verrucae.   Clin Exp Dermatol 21: 2. 93-95 Mar  
Abstract: Treatment with the 585-nm pulsed dye laser was performed in seven patients with viral warts (six with plantar warts and one with a periungual wart) who had failed to respond to conventional therapeutic modalities, including keratolytics, formalin soaks, cryotherapy, curettage, CO2 laser and systemic retinoids. Each patient was and treated on six occasions, separated by intervals of 3 weeks, with fluences of 8.5-9.5 J/cm2. Final follow-up was performed 3 weeks after the final treatment. All patients showed some decrease in the thickness of their warts, this being of a small degree in five of the patients. In the remaining two, there was a moderate reduction in both thickness and wart size. None of the patients experienced complete resolution of their lesions. symptomatic improvement was obtained in all three patients who had previously complained of pain. These data indicate that treatment of resistant viral verrucae of the periungual and plantar skin with the pulsed dye laser is not curative although partial resolution and symptomatic improvement may occur.
Notes:
1995
S C Huilgol, K Liddell, M M Black (1995)  Generalized granuloma annulare sparing vaccination sites.   Clin Exp Dermatol 20: 1. 51-53 Jan  
Abstract: Generalized granuloma annulare (GA) is a chronic and widespread form of GA, less common than the localized type, in which the primary papular lesions may be arranged in either predominantly annular or non-annular configurations. Associations with numerous systemic disorders, including malignancies of the haematopoietic system, have been reported. There is a marked tendency to show the isomorphic or Koebner phenomenon. We report a most unusual case of generalized non-annular GA associated with chronic myelomonocytic leukaemia and myelodysplasia, in which the eruption showed striking sparing of vaccination sites.
Notes:
S C Huilgol, M M Black (1995)  Management of the immunobullous disorders. II. Pemphigus.   Clin Exp Dermatol 20: 4. 283-293 Jul  
Abstract: In the second of our reviews on the management of the immunobullous disorders, we review the therapy of pemphigus disorders, including pemphigus vulgaris, pemphigus vegetans, pemphigus foliaceus, pemphigus erythematosus, pemphigus herpetiformis, drug-induced pemphigus, IgA pemphigus and paraneoplastic pemphigus.
Notes:
S C Huilgol, B S Bhogal, M M Black (1995)  Immunofluorescence of the immunobullous disorders Part two: The clinical disorders.   Indian J Dermatol Venereol Leprol 61: 5. 255-264 Sep/Oct  
Abstract: The immunofluorescence findings in the immunobullous disorders are reviewed together with a summary of clinical and histopathological findings.
Notes:
S C Huilgol, B S Bhogal, M M Black (1995)  Immunofluorescence of the immunobullous disorders part one : Methodology.   Indian J Dermatol Venereol Leprol 61: 4. 187-195 Jul/Aug  
Abstract: In the past two decades the immunofluorescence techniques have greatly contributed to the diagnosis, treatment and understanding of the immunobullous disorders. The methodology of direct and indirect immunofluorescence as applied to the immunobullous disorders is described in detail.
Notes:
1994
S C Huilgol, W A Griffiths, M M Black (1994)  Familial juvenile elastoma.   Australas J Dermatol 35: 2. 87-90  
Abstract: Two cases of familial juvenile elastoma are reported with a review of the literature concerning juvenile elastoma and the Buschke-Ollendorff syndrome of connective tissue naevi in association with osteopoikilosis.
Notes:
Powered by PublicationsList.org.